nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—atherosclerosis	0.779	1	CbGaD
Tyloxapol—LPL—blood vessel—atherosclerosis	0.00931	0.381	CbGeAlD
Tyloxapol—LPL—connective tissue—atherosclerosis	0.00477	0.195	CbGeAlD
Tyloxapol—LPL—cardiovascular system—atherosclerosis	0.00415	0.17	CbGeAlD
Tyloxapol—LPL—adipose tissue—atherosclerosis	0.00366	0.15	CbGeAlD
Tyloxapol—LPL—liver—atherosclerosis	0.00257	0.105	CbGeAlD
Tyloxapol—LPL—Adipogenesis—RETN—atherosclerosis	0.000906	0.00461	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—CETP—atherosclerosis	0.000893	0.00454	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—APOB—atherosclerosis	0.00089	0.00453	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—SCARB1—atherosclerosis	0.000855	0.00435	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOA4—atherosclerosis	0.000849	0.00432	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—APOE—atherosclerosis	0.000732	0.00373	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOA2—atherosclerosis	0.000731	0.00372	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—APOA1—atherosclerosis	0.000724	0.00368	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—ABCA1—atherosclerosis	0.00072	0.00366	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—APOE—atherosclerosis	0.000713	0.00363	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—LDLR—atherosclerosis	0.000707	0.0036	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—APOA1—atherosclerosis	0.000705	0.00358	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—APOB—atherosclerosis	0.000694	0.00353	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—SCARB1—atherosclerosis	0.000661	0.00336	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—HMGCR—atherosclerosis	0.000624	0.00318	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CD36—atherosclerosis	0.000606	0.00308	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—APOB—atherosclerosis	0.000592	0.00301	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.000574	0.00292	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—ALB—atherosclerosis	0.000558	0.00284	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—APOE—atherosclerosis	0.000555	0.00282	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOC3—atherosclerosis	0.000551	0.0028	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—APOA1—atherosclerosis	0.000549	0.00279	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—LDLR—atherosclerosis	0.000547	0.00278	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—atherosclerosis	0.00054	0.00275	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—AHR—atherosclerosis	0.000496	0.00252	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.000483	0.00246	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—APOE—atherosclerosis	0.000474	0.00241	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—CAV1—atherosclerosis	0.000469	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—APOA1—atherosclerosis	0.000468	0.00238	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—SIRT1—atherosclerosis	0.000464	0.00236	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NAMPT—atherosclerosis	0.000434	0.00221	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—CD36—atherosclerosis	0.00038	0.00193	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—ALB—atherosclerosis	0.000371	0.00189	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—ADIPOQ—atherosclerosis	0.000355	0.00181	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOB—atherosclerosis	0.000354	0.0018	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARA—atherosclerosis	0.000353	0.0018	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000347	0.00176	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000341	0.00174	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—LEP—atherosclerosis	0.000335	0.00171	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—APOE—atherosclerosis	0.000328	0.00167	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000321	0.00163	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PPARG—atherosclerosis	0.000319	0.00162	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—INS—atherosclerosis	0.000313	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000301	0.00153	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SOCS3—atherosclerosis	0.000295	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARG—atherosclerosis	0.000292	0.00149	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOE—atherosclerosis	0.000283	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOA1—atherosclerosis	0.00028	0.00143	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000278	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000278	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000273	0.00139	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000234	0.00119	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARA—atherosclerosis	0.000232	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FABP4—atherosclerosis	0.000231	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—AGT—atherosclerosis	0.000225	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—LEP—atherosclerosis	0.000221	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00022	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—IL1B—atherosclerosis	0.000209	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000207	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000207	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000203	0.00103	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—NFKB1—atherosclerosis	0.000199	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000199	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARG—atherosclerosis	0.000192	0.000977	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—INS—atherosclerosis	0.000188	0.000958	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000184	0.000937	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IGF1—atherosclerosis	0.000182	0.000927	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000175	0.000888	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000175	0.000888	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000175	0.000888	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000175	0.000888	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SERPINE1—atherosclerosis	0.000173	0.00088	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000172	0.000877	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MAPK3—atherosclerosis	0.000168	0.000853	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000167	0.000847	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TGFB1—atherosclerosis	0.000166	0.000845	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00016	0.000812	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—atherosclerosis	0.000155	0.000789	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000154	0.000782	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—atherosclerosis	0.000152	0.000773	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LDLRAP1—atherosclerosis	0.000152	0.000773	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000148	0.000755	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLTP—atherosclerosis	0.000143	0.000727	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000132	0.000673	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000132	0.000669	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000131	0.000665	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000128	0.000649	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—atherosclerosis	0.000126	0.000641	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCG8—atherosclerosis	0.000124	0.00063	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LTA4H—atherosclerosis	0.000124	0.00063	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000122	0.000622	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ADIPOQ—atherosclerosis	0.000122	0.000621	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—STAT3—atherosclerosis	0.000118	0.0006	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000115	0.000587	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TGFB1—atherosclerosis	0.000109	0.000556	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOA4—atherosclerosis	0.000108	0.000549	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000103	0.000524	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—atherosclerosis	0.000102	0.000519	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCG1—atherosclerosis	9.79e-05	0.000498	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRH1—atherosclerosis	9.63e-05	0.00049	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOA2—atherosclerosis	9.29e-05	0.000472	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FABP4—atherosclerosis	9.2e-05	0.000468	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LCAT—atherosclerosis	9.2e-05	0.000468	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA4—atherosclerosis	9.03e-05	0.00046	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP7A1—atherosclerosis	8.87e-05	0.000451	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CD36—atherosclerosis	8.59e-05	0.000437	CbGpPWpGaD
Tyloxapol—LPL—Disease—BGN—atherosclerosis	8.58e-05	0.000436	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.46e-05	0.00043	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—atherosclerosis	8.23e-05	0.000419	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP27A1—atherosclerosis	8.2e-05	0.000417	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARA—atherosclerosis	7.99e-05	0.000406	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.88e-05	0.000401	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALOX15—atherosclerosis	7.78e-05	0.000396	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALOX5AP—atherosclerosis	7.78e-05	0.000396	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLA2G2A—atherosclerosis	7.78e-05	0.000396	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA2—atherosclerosis	7.78e-05	0.000396	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCG5—atherosclerosis	7.68e-05	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.67e-05	0.00039	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—LEP—atherosclerosis	7.58e-05	0.000386	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOA4—atherosclerosis	7.55e-05	0.000384	CbGpPWpGaD
Tyloxapol—LPL—Disease—CST3—atherosclerosis	7.48e-05	0.00038	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LPA—atherosclerosis	7.42e-05	0.000377	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BGN—atherosclerosis	7.18e-05	0.000365	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.13e-05	0.000363	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA5—atherosclerosis	7.11e-05	0.000362	CbGpPWpGaD
Tyloxapol—LPL—Disease—NAMPT—atherosclerosis	7.08e-05	0.00036	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOC3—atherosclerosis	6.99e-05	0.000356	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL4—atherosclerosis	6.96e-05	0.000354	CbGpPWpGaD
Tyloxapol—LPL—Disease—LDLR—atherosclerosis	6.95e-05	0.000354	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.91e-05	0.000351	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLA2G1B—atherosclerosis	6.85e-05	0.000348	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.77e-05	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Disease—HSPA1B—atherosclerosis	6.71e-05	0.000342	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.71e-05	0.000341	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.69e-05	0.00034	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALOX5—atherosclerosis	6.61e-05	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—atherosclerosis	6.6e-05	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOA2—atherosclerosis	6.5e-05	0.000331	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCF1—atherosclerosis	6.5e-05	0.000331	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—INS—atherosclerosis	6.47e-05	0.000329	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—UTS2—atherosclerosis	6.2e-05	0.000316	CbGpPWpGaD
Tyloxapol—LPL—Disease—CYBA—atherosclerosis	6.11e-05	0.000311	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.11e-05	0.000311	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—atherosclerosis	6.06e-05	0.000308	CbGpPWpGaD
Tyloxapol—LPL—Disease—PARP1—atherosclerosis	5.98e-05	0.000304	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CX3CR1—atherosclerosis	5.95e-05	0.000303	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASR—atherosclerosis	5.95e-05	0.000303	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NAMPT—atherosclerosis	5.93e-05	0.000302	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.9e-05	0.0003	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LIPC—atherosclerosis	5.89e-05	0.0003	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOC3—atherosclerosis	5.86e-05	0.000298	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CX3CL1—atherosclerosis	5.83e-05	0.000297	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LDLR—atherosclerosis	5.82e-05	0.000296	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CETP—atherosclerosis	5.69e-05	0.000289	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CNR2—atherosclerosis	5.53e-05	0.000281	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SCARB1—atherosclerosis	5.44e-05	0.000277	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.3e-05	0.00027	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMGCR—atherosclerosis	5.14e-05	0.000262	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VWF—atherosclerosis	4.93e-05	0.000251	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOC3—atherosclerosis	4.9e-05	0.000249	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LDLR—atherosclerosis	4.87e-05	0.000248	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL3—atherosclerosis	4.75e-05	0.000242	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.64e-05	0.000236	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCA1—atherosclerosis	4.58e-05	0.000233	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—atherosclerosis	4.56e-05	0.000232	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCF1—atherosclerosis	4.55e-05	0.000232	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NFKB1—atherosclerosis	4.51e-05	0.000229	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOB—atherosclerosis	4.5e-05	0.000229	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR2—atherosclerosis	4.3e-05	0.000219	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDNRA—atherosclerosis	4.3e-05	0.000219	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CYBA—atherosclerosis	4.28e-05	0.000218	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLAT—atherosclerosis	4.19e-05	0.000213	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PARP1—atherosclerosis	4.19e-05	0.000213	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GHRL—atherosclerosis	4.19e-05	0.000213	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCG—atherosclerosis	4.18e-05	0.000212	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—atherosclerosis	4.09e-05	0.000208	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—atherosclerosis	4.05e-05	0.000206	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—atherosclerosis	3.93e-05	0.0002	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK3—atherosclerosis	3.87e-05	0.000197	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—atherosclerosis	3.87e-05	0.000197	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOB—atherosclerosis	3.77e-05	0.000192	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFB—atherosclerosis	3.76e-05	0.000191	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—atherosclerosis	3.75e-05	0.000191	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KNG1—atherosclerosis	3.68e-05	0.000187	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—atherosclerosis	3.66e-05	0.000186	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR1—atherosclerosis	3.66e-05	0.000186	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOE—atherosclerosis	3.6e-05	0.000183	CbGpPWpGaD
Tyloxapol—LPL—Disease—CAV1—atherosclerosis	3.57e-05	0.000181	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLG—atherosclerosis	3.56e-05	0.000181	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOA1—atherosclerosis	3.56e-05	0.000181	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—atherosclerosis	3.51e-05	0.000178	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—atherosclerosis	3.51e-05	0.000178	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD36—atherosclerosis	3.42e-05	0.000174	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SOCS3—atherosclerosis	3.37e-05	0.000172	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS2—atherosclerosis	3.35e-05	0.000171	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP3—atherosclerosis	3.26e-05	0.000166	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF2—atherosclerosis	3.24e-05	0.000165	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—atherosclerosis	3.24e-05	0.000165	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARA—atherosclerosis	3.18e-05	0.000162	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOB—atherosclerosis	3.15e-05	0.00016	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDN1—atherosclerosis	3.1e-05	0.000158	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AGT—atherosclerosis	3.08e-05	0.000157	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL5—atherosclerosis	3.08e-05	0.000156	CbGpPWpGaD
Tyloxapol—LPL—Disease—INS—atherosclerosis	3.07e-05	0.000156	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOE—atherosclerosis	3.01e-05	0.000153	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAV1—atherosclerosis	2.99e-05	0.000152	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA1—atherosclerosis	2.98e-05	0.000152	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCG—atherosclerosis	2.92e-05	0.000149	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPP1—atherosclerosis	2.85e-05	0.000145	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—atherosclerosis	2.83e-05	0.000144	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—atherosclerosis	2.82e-05	0.000144	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—atherosclerosis	2.72e-05	0.000138	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—atherosclerosis	2.7e-05	0.000137	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFB—atherosclerosis	2.64e-05	0.000134	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—atherosclerosis	2.63e-05	0.000134	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—atherosclerosis	2.61e-05	0.000133	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—INS—atherosclerosis	2.58e-05	0.000131	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGT—atherosclerosis	2.57e-05	0.000131	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEP—atherosclerosis	2.52e-05	0.000128	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOE—atherosclerosis	2.52e-05	0.000128	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CAV1—atherosclerosis	2.5e-05	0.000127	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOA1—atherosclerosis	2.49e-05	0.000127	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—atherosclerosis	2.47e-05	0.000125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ESR1—atherosclerosis	2.41e-05	0.000122	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2—atherosclerosis	2.38e-05	0.000121	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—atherosclerosis	2.36e-05	0.00012	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—atherosclerosis	2.27e-05	0.000116	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—atherosclerosis	2.26e-05	0.000115	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INS—atherosclerosis	2.15e-05	0.00011	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL2—atherosclerosis	2.12e-05	0.000108	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—atherosclerosis	2.08e-05	0.000106	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—atherosclerosis	2.07e-05	0.000105	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—atherosclerosis	1.98e-05	0.000101	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—atherosclerosis	1.92e-05	9.79e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—atherosclerosis	1.89e-05	9.61e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK3—atherosclerosis	1.84e-05	9.35e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—atherosclerosis	1.78e-05	9.07e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—atherosclerosis	1.68e-05	8.52e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—atherosclerosis	1.52e-05	7.71e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NFKB1—atherosclerosis	1.5e-05	7.63e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK8—atherosclerosis	1.47e-05	7.5e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—atherosclerosis	1.36e-05	6.92e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—atherosclerosis	1.35e-05	6.85e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—atherosclerosis	1.34e-05	6.84e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK3—atherosclerosis	1.29e-05	6.55e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—atherosclerosis	1.25e-05	6.35e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—atherosclerosis	1.24e-05	6.31e-05	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—atherosclerosis	1.04e-05	5.28e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—atherosclerosis	9.41e-06	4.79e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—atherosclerosis	8.68e-06	4.42e-05	CbGpPWpGaD
